Streetbeat News

Regulatory

TAK

The FDA has accepted Takeda's resubmission of its New Drug Application for TAK-721 (Budesonide Oral Suspension) for the short-term treatment of Eosinophilic Esophagitis.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 12:07 pm

ENVB

Enveric Biosciences (NASDAQ:ENVB) has been granted a new U.S. patent for its EVM301 Series of drug candidates, which are carboxylated psilocybin derivatives aimed at treating mental health disorders. The patent covers novel compositions and pharmaceutical drug formulations, and is expected to strengthen and add value to Enveric's EVM301 Series. The company's CEO believes this could greatly enhance the commercial opportunity of EVM301 Series-based therapies.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 12:06 pm

AAPL

AMZN

GOOG

During a federal antitrust trial, Google's VP for advertising products, Jerry Dischler, expressed concerns about Google's decreasing market share in the advertising industry. He highlighted the increasing competition from companies like Amazon and TikTok. The trial also discussed Google's control over ad pricing and changes in auction dynamics. The outcome of this trial could reshape the digital advertising industry.

Portfolio Pulse from Anusuya Lahiri

September 20, 2023 | 12:06 pm

VIR

Vir Biotechnology has initiated a Phase 1 trial of VIR-1388, a novel T cell vaccine for the prevention of HIV. The first participant has been dosed and initial data from the trial is expected in the second half of 2024.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 12:04 pm

SPRY

ARS Pharma's shares are trading lower following the FDA's Complete Response Letter for the company's neffy epinephrine nasal spray, requesting additional study.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 11:51 am

NTRB

Nutriband has announced a US patent for its AVERSA abuse-deterrent technology. The technology uses taste aversion to prevent the abuse of opioid-based transdermal patches.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 11:36 am

SONN

Sonnet BioTherapeutics has announced data from two radiolabeling studies that validate the tumor targeting attributes associated with albumin binding by the FHAB technology.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2023 | 11:34 am

SPY

USO

A recent headline from Benzinga stating that U.S. President Biden is considering depleting the Strategic Petroleum Reserve was incorrectly attributed to The Wall Street Journal and did not originate from President Biden.

Portfolio Pulse from Charles Gross

September 20, 2023 | 11:26 am

GLD

SPY

UUP

US stock markets closed lower on Tuesday, September 19, as the Federal Reserve began its two-day monetary policy meeting. Housing starts dropped 11.3% in August, while building permits increased 6.9%. The Dow Jones, S&P 500, and Nasdaq Composite all recorded declines. Asian markets also closed lower, with Japan's Nikkei 225, Australia's S&P/ASX 200, China's Shanghai Composite, and Hong Kong's Hang Seng Stock Exchange all recording losses. However, the European STOXX 600 index, Germany's DAX, France's CAC 40, and the U.K.'s FTSE 100 all traded higher. Crude Oil WTI and Brent were trading lower, while Natural Gas, Gold, Silver, and Copper all fell. Dow futures, S&P 500 futures, and Nasdaq 100 futures all rose.

Portfolio Pulse from Akanksha Bakshi

September 20, 2023 | 11:05 am

DG

PINS

QQQ

SPY

Traders are cautiously optimistic about a potential pause in rate hikes by the Federal Reserve, which could trigger a relief rally. The S&P 500 and Nasdaq futures edged higher in anticipation. Stocks were pressured on Tuesday due to a surge in bond yields, elevated oil prices, and anxiety about the Fed decision. In premarket trading on Wednesday, the SPDR S&P 500 ETF Trust (NYSE:SPY) rose 0.18% and the Invesco QQQ ETF (NASDAQ:QQQ) gained 0.14%. Pinterest, Inc. (NYSE:PINS) climbed over 3% in premarket trading after JPMorgan raised the price target for the stock, while Dollar General Corp. (NYSE:DG) fell about 2% in reaction to a downgrade by JPMorgan.

Portfolio Pulse from Shanthi Rexaline

September 20, 2023 | 11:04 am